Microelimination of hepatitis C in dialysis units: results from the Brazilian Registry for the elimination of HCV
Authors:
- Patrícia Ferreira AbreuPAPatrícia Ferreira Abreu
- Pablo Rodrigues Costa AlvesPAPablo Rodrigues Costa Alves
- Paulo Lisboa BittencourtPBPaulo Lisboa Bittencourt
- Isadora Cartaxo de Sousa CalvoICIsadora Cartaxo de Sousa Calvo
- Osvaldo Merege Vieira NetoONOsvaldo Merege Vieira Neto
- Marcelo Mazza Do NascimentoMNMarcelo Mazza Do Nascimento
- Felipe Costa NevesFNFelipe Costa Neves
- Ana Flavia MouraAMAna Flavia Moura
- Daniel Costa Chalabi CalazansDCDaniel Costa Chalabi Calazans
- Juan Miguel Villalobos SalcedoJSJuan Miguel Villalobos Salcedo
- Cristina Melo RochaCRCristina Melo Rocha
- Cirley Maria de Oliveira LobatoCLCirley Maria de Oliveira Lobato
Open Access
- 1 January 2026
- journal article
- Published by FapUNIFESP (SciELO) in Brazilian Journal of Nephrology
- Vol. 48 (4)
Abstract
Introduction: Hepatitis C virus (HCV) infection remains a major public health challenge, particularly among patients undergoing dialysis, who are disproportionately vulnerable and at increased risk of transmission. Micro-elimination strategies targeting high-risk subpopulations are a critical component for achieving the World Health Organization global HCV elimination goals. Methods: This national, multicenter, prospective implementation study was conducted within the framework of the Brazilian Registry for the Elimination of HCV in Dialysis Units. All 904 active dialysis units in the country were invited; 384 (42.5%) joined voluntarily, and, within each, all eligible patients were enrolled (census) between 2021 and 2024. The HCV cascade of care was evaluated, including serological screening (anti-HCV), virological confirmation (HCV-RNA), treatment with direct-acting antivirals (DAAs), and assessment of sustained virologic response (SVR). Results: A total of 66,601 patients were evaluated, yielding a national anti-HCV prevalence of 2.08%. HCV-RNA testing coverage reached 65.4%, with a positivity rate of 64.2% among those tested, resulting in an adjusted prevalence of active viremia of 1.34%. Among patients with detectable viremia, 74.2% initiated antiviral therapy, 92.6% completed treatment, and 93.3% achieved SVR. The main barriers identified along the cascade of care included limited availability of diagnostic tests and patient mortality. Discussion: These findings indicate that Brazil has achieved robust therapeutic effectiveness indicators, placing the country at an advanced stage toward HCV elimination within the dialysis population. Nonetheless, important operational gaps persist, particularly in diagnostic confirmation. Conclusion: Elimination of HCV in dialysis units is an achievable goal in Brazil. Sustained success depends on maintaining universal screening, ensuring prompt treatment initiation for confirmed cases, and strengthening continuous integration between services.Keywords
This publication has 13 references indexed in Scilit:
- Global Burden and Trends of Acute Hepatitis C From 1990 to 2021: An Analysis Based on the 2021 Global Burden of Disease StudyJournal of Viral Hepatitis, 2025
- EASL position paper on clinical follow-up after HCV cureJournal of Hepatology, 2024
- Global epidemiology of hepatitis C virus in dialysis patients: A systematic review and meta-analysisPLOS ONE, 2024
- Hepatitis CThe Lancet, 2023
- The Seroprevalence of Hepatitis C Virus (HCV) in Hemodialysis Patients in Oman: A National Cross-Sectional StudyJournal of Epidemiology and Global Health, 2023
- Persistently high hepatitis C rates in haemodialysis patients in Brazil [a systematic review and meta-analysis]Scientific Reports, 2022
- Global prevalence of hepatitis C in general population: A systematic review and meta-analysisTravel Medicine and Infectious Disease, 2022
- Elimination of Hepatitis C Virus in a Dialysis Population: A Collaborative Care Model in TaiwanAmerican Journal of Kidney Diseases, 2021
- Testing and Clinical Management of Health Care Personnel Potentially Exposed to Hepatitis C Virus — CDC Guidance, United States, 2020MMWR. Recommendations and Reports, 2020
- The prevalence of hepatitis C virus in hemodialysis patients in Pakistan: A systematic review and meta-analysisPLOS ONE, 2020